Healthy Life-Year Costs of Treatment Speed From Arrival to Endovascular Thrombectomy in Patients With Ischemic Stroke
Mohammed Almekhlafi(University of Calgary), Tobien H.C.M.L. Schreuder(Hermes Arzneimittel (Germany)), Boudewijn A.A.M. van Hasselt(Hermes Arzneimittel (Germany)), Tudor G. Jovin(Los Angeles Medical Center), Jan Albert Vos(Hermes Arzneimittel (Germany)), Bart J. Emmer(Amsterdam University Medical Centers), Geert J. Lycklama à Nijeholt(GGD Haaglanden), Paul J. Nederkoorn(Hermes Arzneimittel (Germany)), Willem Jan J. van Rooij(Hermes Arzneimittel (Germany)), Joost Bot(Hermes Arzneimittel (Germany)), Andrew M. Demchuk(Los Angeles Medical Center), Jeannette Hofmeijer(Rijnstate Hospital), Charles B.L.M. Majoie(Academic Medical Center), Leo A.M. Aerden(Hermes Arzneimittel (Germany)), Phil White(Southern General Hospital), Albert J. Yoo(Los Angeles Medical Center), Hester F. Lingsma(Erasmus MC), Debbie Beumer(Maastricht University), Serge Bracard(Inserm), Keith W. Muir(Universität Hamburg), Wouter J. Schonewille(Universität Hamburg), Ewoud J. van Dijk(Hermes Arzneimittel (Germany)), Diederik W.J. Dippel(Sint Lucas Andreas Hospital), Jelis Boiten(University Medical Center Utrecht), Patrick A. Brouwer(Hermes Arzneimittel (Germany)), René J. Dallinga(Hermes Arzneimittel (Germany)), Olvert A. Berkhemer(Erasmus MC), Marieke J.H. Wermer(Leiden University Medical Center), Julie Staals(Maastricht University Medical Centre), Sebastiaan F. de Bruijn(Hermes Arzneimittel (Germany)), Peter Mitchell(University of Melbourne), L. Jaap Kappelle(SUNY Downstate Health Sciences University), Bruce Campbell(University of Melbourne), Jeffrey L. Saver(Comprehensive Clinical Research), Mayank Goyal(Los Angeles Medical Center), Paul L.M. de Kort(Hermes Arzneimittel (Germany)), Lukas C. van Dijk(Hermes Arzneimittel (Germany)), Michael D. Hill(University of Calgary), Marieke C. Visser(Hermes Arzneimittel (Germany)), Françis Guillemin(Inserm), Lucie A. van den Berg(Academic Medical Center), Jan S.P. van den Berg(Hermes Arzneimittel (Germany)), Jacques A. van Oostayen(Hermes Arzneimittel (Germany)), Patrick C. Vroomen(Hermes Arzneimittel (Germany)), Marianne A. A. van Walderveen(Hermes Arzneimittel (Germany)), Puck Fransen, Scott Brown(Altair Engineering (United States)), Rob H. Lo(Hermes Arzneimittel (Germany)), Joost de Vries(Radboud University Nijmegen), Omid Eshghi(Hermes Arzneimittel (Germany))
Cited by 63
Related Papers
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
|Stroke|1993|12.3k
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
|New England Journal of Medicine|2014|6.6k
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
|New England Journal of Medicine|2015|6k
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
|New England Journal of Medicine|2017|5.5k